Search research articles
Contact Us
Filters
Showing results (181-190 of 202) with videos related to
Page
of 21
Sort By:
European Radiology
|
July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
Osman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Life (Basel, Switzerland)
|
June 26, 2026
Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73
Or Schubert, Maria Chiara Sighinolfi, Filippo Gavi, et al.
European Radiology
|
October 31, 2025
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology
|
May 23, 2025
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology
|
September 1, 2021
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
Osman Öcal, Bora Peynircioglu, Christian Loewe, et al.
Cancers
|
March 14, 2026
Retrospective Italian Registry on DSM-TACE: Experience Beyond Current Recommendations
Pierleone Lucatelli, Maria Giulia Travaglini, Elio Damato, et al.
Biomedicines
|
May 28, 2022
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
Thomas Geyer, Philipp M Kazmierczak, Ingo G Steffen, et al.
Cancers
|
January 8, 2023
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
Roberto Iezzi, Afshin Gangi, Alessandro Posa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 2, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
Osman Öcal, Kerstin Schütte, Christoph J Zech, et al.
Cardiovascular and Interventional Radiology
|
September 25, 2020
The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis
Philippe L Pereira, Roberto Iezzi, Riccardo Manfredi, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 202) with videos related to
Sort By:
Page
of 21
European Radiology
|
July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression
Osman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
Life (Basel, Switzerland)
|
June 26, 2026
Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73
Or Schubert, Maria Chiara Sighinolfi, Filippo Gavi, et al.
European Radiology
|
October 31, 2025
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology
|
May 23, 2025
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
Osman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology
|
September 1, 2021
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trial
Osman Öcal, Bora Peynircioglu, Christian Loewe, et al.
Cancers
|
March 14, 2026
Retrospective Italian Registry on DSM-TACE: Experience Beyond Current Recommendations
Pierleone Lucatelli, Maria Giulia Travaglini, Elio Damato, et al.
Biomedicines
|
May 28, 2022
Extrahepatic Disease in Hepatocellular Carcinoma: Do We Always Need Whole-Body CT or Is Liver MRI Sufficient? A Subanalysis of the SORAMIC Trial
Thomas Geyer, Philipp M Kazmierczak, Ingo G Steffen, et al.
Cancers
|
January 8, 2023
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
Roberto Iezzi, Afshin Gangi, Alessandro Posa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 2, 2022
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
Osman Öcal, Kerstin Schütte, Christoph J Zech, et al.
Cardiovascular and Interventional Radiology
|
September 25, 2020
The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis
Philippe L Pereira, Roberto Iezzi, Riccardo Manfredi, et al.
Page
of 21